278 related articles for article (PubMed ID: 18930458)
1. Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice.
Osman E; Evans V; Graham IR; Athanasopoulos T; McIntosh J; Nathwani AC; Simons JP; Dickson G; Owen JS
Atherosclerosis; 2009 May; 204(1):121-6. PubMed ID: 18930458
[TBL] [Abstract][Full Text] [Related]
2. Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8.
Kitajima K; Marchadier DH; Miller GC; Gao GP; Wilson JM; Rader DJ
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1852-7. PubMed ID: 16763161
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle.
Evans VC; Graham IR; Athanasopoulos T; Galley DJ; Jackson CL; Simons JP; Dickson G; Owen JS
Metabolism; 2011 Apr; 60(4):491-8. PubMed ID: 20580777
[TBL] [Abstract][Full Text] [Related]
4. Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7).
Evans V; Foster H; Graham IR; Foster K; Athanasopoulos T; Simons JP; Dickson G; Owen JS
Hum Gene Ther; 2008 Jun; 19(6):569-78. PubMed ID: 18578629
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
6. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
Tsukamoto K; Tangirala R; Chun SH; Puré E; Rader DJ
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2162-70. PubMed ID: 10479659
[TBL] [Abstract][Full Text] [Related]
7. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E.
Harris JD; Schepelmann S; Athanasopoulos T; Graham IR; Stannard AK; Mohri Z; Hill V; Hassall DG; Owen JS; Dickson G
Gene Ther; 2002 Jan; 9(1):21-9. PubMed ID: 11850719
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
10. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.
Tsukamoto K; Smith P; Glick JM; Rader DJ
J Clin Invest; 1997 Jul; 100(1):107-14. PubMed ID: 9202062
[TBL] [Abstract][Full Text] [Related]
11. Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE.
Harris JD; Graham IR; Schepelmann S; Stannard AK; Roberts ML; Hodges BL; Hill V; Amalfitano A; Hassall DG; Owen JS; Dickson G
Hum Mol Genet; 2002 Jan; 11(1):43-58. PubMed ID: 11772998
[TBL] [Abstract][Full Text] [Related]
12. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA.
Rinaldi M; Catapano AL; Parrella P; Ciafrè SA; Signori E; Seripa D; Uboldi P; Antonini R; Ricci G; Farace MG; Fazio VM
Gene Ther; 2000 Nov; 7(21):1795-801. PubMed ID: 11110410
[TBL] [Abstract][Full Text] [Related]
13. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.
Roche-Molina M; Sanz-Rosa D; Cruz FM; García-Prieto J; López S; Abia R; Muriana FJ; Fuster V; Ibáñez B; Bernal JA
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):50-9. PubMed ID: 25341796
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice.
Athanasopoulos T; Owen JS; Hassall D; Dunckley MG; Drew J; Goodman J; Tagalakis AD; Riddell DR; Dickson G
Hum Mol Genet; 2000 Oct; 9(17):2545-51. PubMed ID: 11030760
[TBL] [Abstract][Full Text] [Related]
15. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
[TBL] [Abstract][Full Text] [Related]
16. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E delivery by peritoneal implantation of encapsulated recombinant cells improves the hyperlipidaemic profile in apoE-deficient mice.
Tagalakis AD; Diakonov IA; Graham IR; Heald KA; Harris JD; Mulcahy JV; Dickson G; Owen JS
Biochim Biophys Acta; 2005 Jan; 1686(3):190-9. PubMed ID: 15629688
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effects of Diet-Induced Lipid Lowering Versus Lipid Lowering Along With Apo A-I Milano Gene Therapy on Regression of Atherosclerosis.
Wang L; Tian F; Arias A; Yang M; Sharifi BG; Shah PK
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):320-8. PubMed ID: 26499098
[TBL] [Abstract][Full Text] [Related]
20. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]